Close
What would you like to look for?
Site search
Search filters

Cisco to acquire Isovalent

8 January 2024

Cisco (NASDAQ: CSCO) intends to acquire Isovalent, a leader in open source cloud native networking and security, to bolster its secure networking capabilities across public clouds

Lallemand subsidiary Danstar Ferment AG takes over Evolva AG

4 January 2024

On 28 December 2023, Danstar Ferment AG, a Swiss subsidiary of Canadian multi-national, Lallemand Inc., has successfully completed the acquisition of Swiss based Evolva AG, subsidiary of SIX listed Evolva Holding SA.

Combination of Proteomedix and Blue Water Biotech to form Onconetix

20 December 2023

Proteomedix AG, ein privates Schweizer Diagnostikunternehmen im kommerziellen Stadium, und Blue Water Biotech, Inc.

Constructor Group reorganizes its corporate structure in Switzerland

12 December 2023

Through its for-profit and nonprofit entities that combine notably a university, a research center, businesses, consulting services, incubation, and funding, Constructor Group aims to provide innovative education that covers the...

SWIMRUN expands into the US market with investment in Ödyssey Series

30 November 2023

SWIMRUN AG, the organizer of major swimrun events, has acquired a majority stake in Swimrun USA Inc., which owns all rights to the Ödyssey Swimrun Series in the United States. Following the transaction, SWIMRUN will be the market...

Infosim takes over SKOOR

28 November 2023

The software company Infosim GmbH & Co. KG, based in Würzburg, a leading international provider of automated service fulfilment and service assurance solutions for telcos, ISPs, managed service providers and enterprises, has...

VISCHER advises Bregal on the acquisition of Netrics Group

22 November 2023

Funds advised by Bregal Unternehmerkapital acquire Netrics Group, one of the largest cloud and modern workplace providers in Switzerland, from Waterland Private Equity. The transaction is accompanied by a reinvestment of the...

Nouscom Raises EUR 67.5m in Oversubscribed Series C Financing Round

14 November 2023

Nouscom AG, a clinical stage immuno-oncology company developing off-the-shelf and personalized viral vector-based cancer vaccines targeting neoantigens, today announced the completion of its oversubscribed Series C equity financing raising EUR 67.5m (USD 72m) from a syndicate of re-nowned international healthcare investors.

LimmaTech Biologics Raises USD 37m Series A to Advance Its Pipeline of Vaccines Against Multidrug-Resistant Bacterial Infections

12 October 2023

LimmaTech Biologics AG announced the closing of a USD 37m (CHF 33m) Series A financing round co-led by Adjuvant Capital, AXA IM Alts, and the Novo Holdings REPAIR Impact Fund.

Afinum invests in Hofstetter PCB AG

18 September 2023

Afinum invests in Hofstetter PCB AG (Hofstetter), the leading European provider of printed circuit boards plating and special final finishing services.